Helicobacter pylori: an emerging infectious disease.
Helicobacter pylori is the most common chronic bacterial infection in the world, colonizing the stomachs of more than 50% of the human population. The discovery of this bacterium has changed the concept of care and management for peptic ulcer disease, mucosa-associated lymphomas, gastritis, and gastric carcinoma. Although the mode of transmission is not definitively known, person-to-person contact is suspected. This article discusses H. pylori, the associated clinical syndromes and diseases, risk factors, and current pharmacologic management.
McManus
T J
TJ
United States Air Force NC, United States Air Force Academy, Colorado Springs, USA.
D000658:Amoxicillin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D015994:Incidence; D010406:Penicillins / Q000008:administration & dosage*
D010406:Penicillins; D000658:Amoxicillin